IP Library Granted Patent US 8,598,198
Granted Patent B2
US 8,598,198 · App. 12/725,251 · Granted Dec 3, 2013

Nucleic acid binding dyes and uses therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,598,198
App. No.
12/725,251
Granted
Dec 3, 2013
Kind
B2
Abstract

The invention provides novel compounds and compositions of Formulas I and II, as well as methods of using them. The compounds can be used, for example, to quantify an amount of double stranded DNA in a sample subjected to nucleic acid amplification, or for real time monitoring of a nucleic acid amplification reaction. The compounds can be provided in a kit, for example, with other reagents and instructions for using the compounds and reagents.

Claims (23)

1. A compound of Formula I:

wherein

R 1 , R 2 and R 3 are each H

Y is S or O;

W taken together with the atoms to which it is attached is a 6 membered heterocyclic ring;

n is 0;

Q is Q2:

wherein

Y is —CR 13 ═CR 14 —; m is 1 and p is 0;

R 6 is unsubstituted (C 1 -C 8 )alkyl, unsubstituted aryl, or unsubstituted (C 1 -C 8 )alkaryl;

R 9 , R 11 , and R 12 are each independently H, amino, or halo;

R 10 is H, methoxy, amino or halo;

one of R 13 and R 14 is H and the other is NR 15 R 16 ;

R 15 is (C 1 -C 6 )alkyl or (C 1 -C 6 )alkyl-NR 17 R 18 or C 3 H 7 N + (CH 3 ) 3 , wherein R 17 and R 18 are each independently H or (C 1 -C 6 )alkyl; and

R 16 is (C 1 -C 6 )alkyl-NR 17 R 18 or C 3 H 7 —N + (CH 3 ) 3 , wherein R 17 and R 18 are each independently H or (C 1 -C 6 )alkyl;

or a salt thereof.

2. The compound of claim 1 wherein R 1 , R 2 and R 3 are each H; Y is S; and n is 0.

3. The compound of claim 1 wherein Q is Q2; m is 1; R 6 is methyl, ethyl, propyl, phenyl, benzyl, 2-phenylethyl, or 3-phenylpropyl; R 9 , R 10 , R 11 , and R 12 are each H; R 13 is H; R 14 is NR 15 R 16 wherein R 15 is methyl, ethyl, propyl, or butyl.

4. The compound of claim 3 wherein R 16 is (C 1 -C 3 )alkyl-N(Me) 2 .

5. The compound of claim 1 wherein the compound is a compound of formula II:

wherein

R 6 is methyl, ethyl, propyl, phenyl, benzyl, 2-phenylethyl, or 3-phenylpropyl; and R 14 is

6. The compound of claim 1 wherein the compound displays enhanced emission in the presence of nucleic acids, in either in vitro or in vivo environments, compared to its emission in the same environment lacking nucleic acids.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2010
From: MCDOUGALL, MARK; DWIGHT, STEPHEN
To: PROMEGA CORPORATION
Reel/Frame 024436/0828 →